| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |